[Central venous infusion of dopamine. Changes in dose during central venous pressure measurement]. 1993

C Guiglio, and D Haro, and R Muchada
Département d'Anesthésie-Réanimation, Clinique Mutualiste E. André, Lyon.

The changes in the doses of dopamine administered at a steady rate which occur during central venous pressure (CVP) measurement were studied. A workbench model with a single lumen central venous catheter was devised with which a mathematical model was constructed to calculate the alterations due to changes in different variables: central venous pressure, dopamine dose, collateral infusions. The average time for CVP measurement was 2 min. The volume of 5% glucose solution filling the manometer was 2.3 ml. The dopamine bolus generated by CVP measurement was equivalent to a dose of 85 micrograms.kg-1 x min-1. The delay required for a return to the initial dose was 2 h 42 min. Changes in CVP led to inversely proportional changes in dopamine dose. These also depended on the level to which the measuring tube was filled before carrying out the measurement. High initial rates of dopamine infusion required shorter times for a return to initial dopamine doses. The bolus and time for recovery were also inversely proportional to the volume of infusion fluids given at a steady rate on the same venous line. This model was tested in a patient suffering from bacterial pneumonia and septic shock (60 years, 55 kg). CVP measurement resulted in a bolus dose of 17 micrograms.kg-1 x min-1, leading to a 43% decrease in aortic flow rate and 60% in the ejection volume. After about 25 min, heart rate and mean arterial blood pressure had returned to their initial values, although aortic flow rate remained 30% below initial values. This problem is also met with other drugs, such as heparin.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D002496 Central Venous Pressure The blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity. Venous Pressure, Central,Central Venous Pressures,Pressure, Central Venous,Pressures, Central Venous,Venous Pressures, Central
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004868 Equipment Failure Failure of equipment to perform to standard. The failure may be due to defects or improper use. Defects, Equipment,Device Failure,Failure, Equipment,Malfunction, Equipment,Medical Device Failure,Misuse, Equipment,Device Failure, Medical,Device Failures, Medical,Failure, Medical Device,Failures, Medical Device,Defect, Equipment,Device Failures,Equipment Defect,Equipment Defects,Equipment Failures,Equipment Malfunction,Equipment Malfunctions,Equipment Misuse,Equipment Misuses,Failure, Device,Failures, Device,Failures, Equipment,Malfunctions, Equipment,Misuses, Equipment
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear

Related Publications

C Guiglio, and D Haro, and R Muchada
January 1969, Nordisk medicin,
C Guiglio, and D Haro, and R Muchada
January 2000, Nursing times,
C Guiglio, and D Haro, and R Muchada
May 1967, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
C Guiglio, and D Haro, and R Muchada
January 1975, Anaesthesia,
C Guiglio, and D Haro, and R Muchada
December 1969, Minerva anestesiologica,
C Guiglio, and D Haro, and R Muchada
May 1991, Soins; la revue de reference infirmiere,
C Guiglio, and D Haro, and R Muchada
November 1969, Nursing mirror and midwives journal,
C Guiglio, and D Haro, and R Muchada
August 1969, Lancet (London, England),
C Guiglio, and D Haro, and R Muchada
April 1971, Lancet (London, England),
Copied contents to your clipboard!